NCT01936168View on ClinicalTrials.gov

MOCA Versus RFA in the Treatment of Primary Great Saphenous Varicose Veins

NACompletedINTERVENTIONAL
Enrollment

213

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Greater Saphenous Vein Injury
Interventions
DEVICE

Mechanochemical Endovenous Ablation (MOCA)

Mechanochemical Endovenous Ablation (MOCA)for treatment of great saphenous vein incompetence

PROCEDURE

Radiofrequency ablation (RFA)

Radiofrequency ablation (RFA)for treatment of great saphenous vein incompetence

Trial Locations (5)

Unknown

Rijnstate Hospital, Arnhem

BovenIJ Hospital, Amsterdam

OLVG, Amsterdam

UMCG, Groningen

St. Antonius Hospital, Nieuwegein

All Listed Sponsors
collaborator

St. Antonius Hospital

OTHER

collaborator

OLVG

NETWORK

collaborator

BovenIJ Hospital

OTHER

lead

Rijnstate Hospital

OTHER

NCT01936168 - MOCA Versus RFA in the Treatment of Primary Great Saphenous Varicose Veins | Biotech Hunter | Biotech Hunter